Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy

By Coogan C.L.   Bostwick D.G.   Bloom K.J.   Gould V.E.  

Urology, Vol. 61, Iss. 1, 2003-01 ,pp. : 248-252

Elsevier

Access to resources Recommend Favorite

Hormonal therapy for prostate cancer: primum non nocere

By Milbank A.J.   Dreicer R.   Klein E.A.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 738-741

Elsevier

Access to resources Recommend Favorite

Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomy

By Kollermann J.   Caprano J.   Budde A.   Weidenfeld H.   Weidenfeld M.   Hopfenmuller W.   Helpap B.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 476-480

Elsevier

Access to resources Recommend Favorite

A 10-Year Clinical Experience with Intermittent Hormonal Therapy for Prostate Cancer

By Prapotnich D.   Fizazi K.   Escudier B.   Mombet A.   Cathala N.   Vallancien G.  

European Urology, Vol. 43, Iss. 3, 2003-03 ,pp. : 233-240

Elsevier

Access to resources Recommend Favorite

Combined hormonal and radiation therapy for lymph node-positive prostate cancer

By Whittington R.   Malkowicz S.B.   Barnes M.M.   Broderick G.A.   Van Arsdalen K.   Dougherty M.J.   Wein A.J.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite